bf/AMEX:CATX_icon.jpeg

COM:PERSPECTIVETHERAPEUTICS

Perspective Therapeutics

  • Stock

Last Close

12.28

25/09 14:39

Market Cap

900.16M

Beta: -

Volume Today

144.76K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Dec '22
average inventory
382.65K
-
381.85K
0.21%
369.18K
3.32%
328.70K
10.96%
419.50K
27.62%
523K
24.67%
587.50K
12.33%
812.50K
38.30%
1.19M
46.22%
1.40M
18.06%
average payables
503.71K
-
536.55K
6.52%
554.42K
3.33%
620.29K
11.88%
1.01M
62.91%
1.04M
2.62%
668.50K
35.54%
692K
3.52%
848K
22.54%
1.25M
47.82%
average receivables
950.71K
-
1.02M
7.01%
836.82K
17.75%
665.49K
20.47%
959K
44.10%
1.17M
22.31%
1.60M
36.32%
2.03M
26.86%
1.81M
10.75%
1.49M
17.95%
book value per share
0.56
-
0.38
32.54%
0.30
21.27%
0.19
35.36%
0.09
52.68%
0.11
25.62%
0.08
26.10%
0.65
666.76%
0.43
33.52%
0.38
10.90%
capex per share
-0.00
-
-0.00
219.69%
-0.01
224.35%
-0.01
11.64%
-0.01
38.77%
-0.01
8.40%
-0.00
39.02%
-0.00
9.15%
-0.00
48.94%
-0.00
13.44%
capex to depreciation
-0.05
-
-0.26
388.91%
-1.04
298.00%
-8.07
673.03%
-4.21
47.82%
-3.26
22.50%
-1.86
43.11%
-2.56
37.69%
-1.07
58.05%
-0.88
18.15%
capex to operating cash flow
0.01
-
0.04
276.86%
0.13
194.82%
0.10
24.09%
0.06
38.62%
0.09
49.05%
0.07
14.74%
0.13
79.11%
0.03
74.31%
0.02
28.09%
capex to revenue
-0.01
-
-0.03
276.57%
-0.10
214.04%
-0.12
11.84%
-0.06
50.66%
-0.06
6.69%
-0.03
53.54%
-0.04
34.38%
-0.02
34.98%
-0.04
72.52%
cash per share
0.41
-
0.27
35.85%
0.23
15.31%
0.16
27.57%
0.06
61.92%
0.08
27.94%
0.04
55.46%
0.61
1,637.14%
0.39
35.96%
0.31
21.77%
days of inventory on hand
29.74
-
33.21
11.70%
26.30
20.81%
30.05
14.25%
46.15
53.57%
45.34
1.76%
51.67
13.98%
72.53
40.35%
82.46
13.70%
94.02
14.01%
days payables outstanding
47.52
-
40.97
13.78%
48.03
17.24%
58.62
22.04%
124.41
112.25%
58.42
53.04%
52.39
10.32%
54.02
3.11%
57.06
5.62%
102.83
80.20%
days sales outstanding
83.58
-
84.68
1.31%
46.30
45.32%
55.66
20.21%
73.46
31.98%
57.59
21.60%
77.07
33.83%
73.09
5.17%
54.37
25.61%
70.03
28.80%
debt to assets
0.12
-
0.01
90.46%
0.01
26.21%
debt to equity
0.18
-
0.01
93.44%
0.01
25.72%
dividend yield
0.00
-
0.00
63.92%
0.00
69.70%
0.00
42.87%
0.00
39.64%
0.00
9.70%
0.00
27.39%
0.00
62.72%
earnings yield
-0.04
-
-0.05
1.26%
-0.10
117.18%
-0.18
80.63%
-0.27
51.83%
-0.18
34.63%
-0.09
51.06%
-0.04
55.56%
-0.16
323.47%
-0.41
154.10%
enterprise value
125.47M
-
76.00M
39.43%
37.72M
50.36%
28.73M
23.85%
22.22M
22.65%
22.16M
0.27%
36.47M
64.56%
20.02M
45.10%
-11.35M
156.69%
14.53M
228.04%
enterprise value over ebitda
-32.25
-
-18.75
41.86%
-8.59
54.20%
-4.64
45.95%
-3.32
28.55%
-4.18
26.02%
-10.49
151.01%
-5.84
44.33%
1.54
126.29%
-0.98
163.78%
ev to operating cash flow
-38.87
-
-21.58
44.48%
-9.71
54.99%
-5.03
48.22%
-3.89
22.65%
-4.39
12.82%
-10.02
128.20%
-7.06
29.54%
1.47
120.86%
-1.19
181.10%
ev to sales
29.74
-
16.50
44.52%
7.91
52.06%
6.03
23.71%
3.75
37.82%
3.03
19.24%
3.77
24.34%
1.99
47.14%
-1.05
152.79%
2.05
294.57%
free cash flow per share
-0.08
-
-0.07
12.52%
-0.08
18.84%
-0.11
43.08%
-0.11
3.64%
-0.08
25.29%
-0.06
29.33%
-0.03
46.48%
-0.06
81.27%
-0.09
56.27%
free cash flow yield
-0.02
-
-0.05
84.41%
-0.09
102.17%
-0.18
97.59%
-0.24
34.91%
-0.20
18.00%
-0.10
48.26%
-0.04
62.53%
-0.18
367.79%
-0.35
93.77%
graham net net
0.37
-
0.24
34.99%
0.21
15.65%
0.15
29.16%
0.04
73.20%
0.07
80.24%
0.02
73.25%
0.60
3,116.25%
0.38
36.40%
0.30
23.12%
graham number
1.33
-
0.76
43.08%
0.76
0.25%
0.70
8.05%
0.50
28.36%
0.43
13.50%
0.30
29.72%
0.67
120.63%
0.70
4.45%
0.95
35.12%
income quality
0.54
-
0.96
76.61%
0.82
13.82%
0.93
12.43%
0.85
8.03%
0.98
15.13%
1.06
7.65%
0.84
20.72%
1.06
26.58%
0.83
21.74%
intangibles to total assets
0.01
-
0.01
2.38%
0.01
3.63%
0.02
125.43%
0.03
41.68%
0.02
35.26%
0.02
7.73%
0.00
88.36%
0.00
10.06%
0.00
10.84%
interest coverage
-5.20K
-
-1.96K
62.31%
-5.35K
173.14%
43.50
100.81%
232.03
433.45%
-62.11
-
interest debt per share
0.00
-
0.00
94.97%
0.00
57.19%
-0.00
15,362.88%
-0.00
80.05%
0.01
-
0.01
49.73%
0.00
39.40%
inventory turnover
12.27
-
10.99
10.47%
13.88
26.27%
12.15
12.47%
7.91
34.88%
8.05
1.80%
7.06
12.26%
5.03
28.75%
4.43
12.05%
3.88
12.29%
invested capital
0.18
-
0.01
93.44%
0.01
25.72%
market cap
133.15M
-
81.23M
39.00%
47.86M
41.07%
34.66M
27.58%
24.82M
28.39%
27.49M
10.74%
37.86M
37.72%
83.07M
119.44%
44.02M
47.02%
35.53M
19.29%
net current asset value
16.62M
-
14.10M
15.14%
11.93M
15.43%
8.62M
27.70%
3.04M
64.71%
5.57M
83.14%
2.53M
54.58%
64.29M
2,440.18%
56.17M
12.64%
49.77M
11.40%
net debt to ebitda
1.97
-
1.29
34.68%
2.31
78.99%
0.96
58.47%
0.39
59.51%
1.00
158.86%
0.40
60.28%
18.39
4,509.58%
7.49
59.27%
1.41
81.11%
net income per share
-0.14
-
-0.07
51.97%
-0.09
27.67%
-0.11
30.80%
-0.12
8.45%
-0.07
40.44%
-0.05
33.16%
-0.03
36.51%
-0.05
64.09%
-0.10
104.92%
operating cash flow per share
-0.08
-
-0.06
15.17%
-0.07
10.02%
-0.10
47.06%
-0.10
0.26%
-0.08
27.27%
-0.05
28.48%
-0.03
49.27%
-0.05
98.75%
-0.09
57.74%
payables turnover
7.68
-
8.91
15.99%
7.60
14.70%
6.23
18.06%
2.93
52.88%
6.25
112.94%
6.97
11.51%
6.76
3.02%
6.40
5.32%
3.55
44.51%
receivables turnover
4.37
-
4.31
1.29%
7.88
82.89%
6.56
16.81%
4.97
24.23%
6.34
27.55%
4.74
25.28%
4.99
5.45%
6.71
34.43%
5.21
22.36%
research and ddevelopement to revenue
0.16
-
0.13
15.81%
0.11
17.04%
0.20
83.07%
0.29
45.44%
0.20
31.63%
0.12
42.28%
0.14
22.03%
0.24
68.50%
0.37
53.13%
return on tangible assets
-0.23
-
-0.16
28.69%
-0.26
62.57%
-0.51
95.04%
-0.92
80.38%
-0.52
43.27%
-0.38
27.09%
-0.05
88.12%
-0.11
145.14%
-0.25
127.46%
revenue per share
0.10
-
0.08
15.10%
0.09
3.28%
0.09
0.18%
0.11
24.08%
0.11
1.60%
0.14
31.25%
0.10
32.39%
0.08
21.47%
0.05
34.25%
roe
-0.25
-
-0.18
28.80%
-0.29
62.16%
-0.58
102.35%
-1.33
129.18%
-0.63
52.59%
-0.57
9.55%
-0.05
91.72%
-0.12
146.81%
-0.27
129.99%
roic
-0.24
-
-0.17
27.20%
-0.29
66.42%
-0.58
103.50%
-1.33
129.30%
-0.65
51.35%
-0.43
34.19%
-0.05
89.00%
-0.12
148.64%
-0.28
138.19%
sales general and administrative to revenue
0.59
-
0.52
11.64%
0.79
52.37%
0.82
3.65%
0.70
14.55%
0.57
18.88%
0.47
17.22%
0.47
1.18%
0.61
31.44%
1.53
149.38%
shareholders equity per share
0.56
-
0.38
32.54%
0.30
21.27%
0.19
35.36%
0.09
52.68%
0.11
25.62%
0.08
26.10%
0.65
666.76%
0.43
33.52%
0.38
10.90%
stock based compensation to revenue
0.04
-
0.04
1.08%
0.06
36.61%
0.08
28.36%
0.10
31.16%
0.06
43.97%
0.05
10.95%
0.04
24.91%
0.10
162.25%
0.19
87.88%
tangible asset value
23.73M
-
20.58M
13.27%
16.25M
21.05%
10.37M
36.17%
4.83M
53.41%
7.52M
55.59%
5.58M
25.71%
67.28M
1,104.58%
61.17M
9.08%
54.56M
10.81%
tangible book value per share
0.56
-
0.38
32.56%
0.30
21.24%
0.19
36.18%
0.09
53.53%
0.11
28.01%
0.08
26.33%
0.65
684.19%
0.43
33.50%
0.38
10.89%
working capital
18.06M
-
15.23M
15.66%
12.54M
17.71%
9.19M
26.73%
3.63M
60.45%
6.19M
70.49%
3.93M
36.52%
65.50M
1,565.84%
57.06M
12.88%
50.54M
11.43%

All numbers in (except ratios and percentages)